Velso 100/400mg Tablets combine two potent antiviral agents  Velpatasvir 100mg and Sofosbuvir 400mg formulated to treat chronic Hepatitis C virus HCV infection in adults. This fixed-dose combination targets the virus at multiple stages of replication, effectively stopping its growth and promoting complete viral clearance.

The therapy is pan genotypic, meaning it is effective against all major HCV genotypes 1–6, and offers a single-tablet daily regimen that simplifies long-term treatment adherence.

Uses / Indications:

Treatment of chronic Hepatitis C infection (genotypes 1–6)

Suitable for patients with or without cirrhosis

Used in combination or monotherapy, depending on liver condition

Aims to achieve Sustained Virologic Response (SVR) or viral cure

Dosage / Administration:

Recommended dose: One tablet once daily, with or without food.

Duration of therapy: 12 weeks, or as prescribed by a hepatologist.

Swallow whole; do not crush or chew.

Follow physician instructions for dosage and lab monitoring.

Benefits:

High cure rate (over 95%) in Hepatitis C patients.

Pan-genotypic efficacy covers all types of HCV infection.

Improves liver function and reduces viral load.

Prevents complications such as cirrhosis and liver failure.

Convenient once-daily dosing enhances treatment adherence.

Possible Alternates:

Epclusa Tablet (Sofosbuvir + Velpatasvir)

Hepcvel Tablet

Velasof Tablet

Abriva Plus 400/100mg Tablet

Precautions:

Use only under medical supervision.

Not recommended for children under 18 years.

Avoid alcohol and hepatotoxic substances during therapy.

Pregnant or breastfeeding women should consult a doctor before use.

Store below 30°C in a cool, dry place, away from direct sunlight.

Velso 100/400mg Tablets (Velpatasvir + Sofosbuvir) offer a complete, once-daily antiviral regimen for Hepatitis C, providing high cure rates and improved liver health. Purchase Velso Tablets at the best online price in Pakistan from Mr Medicine Mart with secure nationwide delivery.

​